The Surprising Reason NMN Works — and Why Your Gut Holds the Key
- Jun 24
- 5 min read
A 2026 human trial revealed something unexpected about
how your body actually uses it.
For years, the story of cellular energy and aging centred almost entirely on one molecule: NAD⁺, the coenzyme every cell relies on to produce energy and carry out repairs. The thinking was straightforward — NAD⁺ declines with age, so replenishing it should help.
That story is still true. But the newest research is adding a character almost nobody expected to find at the centre of it: the trillions of bacteria living in your gut.
The Surprising Detour
When you take an NAD⁺ precursor like NMN, the intuitive assumption is that it travels straight to your cells and turns into NAD⁺. The reality is more roundabout — and more interesting.
The clearest evidence yet came in early 2026, when scientists at Nestlé Research published a study in Nature Metabolism, one of the most respected journals in the field. Until then, the idea that gut bacteria help process NAD⁺ precursors had only been shown in animals. This was the first randomized, placebo-controlled trial to confirm it in people — a head-to-head comparison of three different NAD⁺ boosters in 65 healthy adults.
The finding: rather than being absorbed directly, much of an oral dose of NMN is first processed by gut bacteria, which convert it into another compound the body then uses to build NAD⁺. Your gut microbes aren't a passageway — they're an active step in the process.
This also helps explain why NAD⁺ supplements don't work identically for everyone. Two people with different gut bacteria may handle the very same dose differently.
The takeaway is simple: your gut isn't just where these compounds are absorbed. It's part of how they work.
Why This Explains a Long-Standing Puzzle
This discovery helps make sense of something that has puzzled researchers for years: NMN doesn’t seem to work equally well for everyone.
In clinical trials, some people show a strong rise in NAD⁺ after taking NMN, while others show much less. Researchers have started calling these groups “responders” and “non-responders.” Part of the explanation appears to lie in each person’s cellular makeup — whether their cells lean toward producing NAD⁺ or consuming it more quickly.
But the gut microbiome adds another layer. Since everyone’s microbiome is different — shaped by diet, environment, and lifestyle — it is reasonable to think two people taking an identical NMN dose could process it quite differently, simply because their gut bacteria differ. The same supplement, two different internal ecosystems, two different results.
This reframes NMN in an important way. It isn’t a simple switch that produces the same output in every body. It is a compound that works in partnership with systems already inside you — and the state of those systems matters.
The Two-Way Street Between Gut and Cell
The relationship appears to run in both directions, which is what makes this area so compelling.
Gut bacteria help shape how NMN becomes NAD⁺. At the same time, the gut produces its own family of beneficial compounds — short-chain fatty acids, made when bacteria ferment the fibre you eat. These compounds are consistently linked in research to a healthier gut lining, lower inflammation, and better metabolic health.
What’s emerging is a picture of cellular energy that isn’t confined to the inside of your cells at all. It is a network: the food you eat feeds your gut bacteria, your gut bacteria influence both inflammation and how NAD⁺ precursors are processed, and NAD⁺ in turn powers the cellular machinery that keeps you feeling energetic. Each part depends on the others.
What This Means for You
This is still an emerging field, and much of the most detailed mechanism work comes from animal studies, with human research actively catching up. So the practical guidance is measured rather than dramatic — but it points in a clear and encouraging direction.
If your gut health influences how well your body uses an NAD⁺ precursor, then supporting your gut isn’t separate from supporting your cellular energy — it is part of the same effort. The fundamentals that feed a healthy microbiome are ones you already know:
 | Fibre and plant variety — the raw material your gut bacteria ferment into beneficial short-chain fatty acids. Traditional Japanese cooking is rich in these: root vegetables like gobō (burdock) and daikon, leafy greens, and imo (taro and sweet potato). |
 | Sea vegetables — wakame, kombu, nori, and hijiki provide a distinct type of fibre that feeds beneficial gut bacteria, found in few diets outside Japan. |
 | Fermented foods — miso, natto, tsukemono (pickled vegetables), and umeboshi introduce beneficial microbes directly. These have been dietary staples in Japan for centuries. |
· Less ultra-processed food — the traditional Japanese table, built on rice, vegetables, soy, and fish, naturally contained very little of the refined, packaged food that research associates with a less diverse, less resilient microbiome. None of this is exotic, and that is rather the point. The newest, most futuristic-sounding research on cellular aging keeps circling back to the least futuristic advice imaginable: feed your gut well.
Where NMN Fits Now
Seen through this lens, NMN’s role becomes simple and honest: it works best when your body is already well looked after. The same habits that support your energy in the first place — good food, regular movement, quality sleep, a healthy gut — also help your body make the most of NMN. NMN isn’t a shortcut that replaces those habits. It works alongside them.
This is the most encouraging part of the new research. Your cellular vitality isn’t decided by any single thing — not one supplement, not one food, not one habit. It comes from all of them working together. And the more we learn, the clearer one message becomes: a healthy gut is becoming just as important to healthy aging as the cells themselves.
A NOTE ON THIS ARTICLE
This article is written for educational and informational purposes only and is not medical advice. The research described here — including the 2026 human trial published in Nature Metabolism — represents a promising and fast-developing area of science, and our understanding continues to evolve as more studies are completed. Individual health situations vary, and any changes to diet or supplementation should be discussed with a qualified healthcare professional. NMN has not been evaluated by the FDA for the diagnosis, treatment, cure, or prevention of any disease.
Key References
Christen S, Redeuil K, Goulet L, et al. The differential impact of three different NAD⁺ boosters on circulatory NAD and microbial metabolism in humans. Nat Metab. 2026 Jan 15. (Epub ahead of print)
Benjamin C, Crews R. Nicotinamide mononucleotide supplementation: understanding metabolic variability and clinical implications. Metabolites. 2024;14(6):341.
Shats I, Williams JG, Liu J, et al. Bacteria boost mammalian host NAD metabolism by engaging the deamidated biosynthesis pathway. Cell Metab. 2020;31(3):564–579.
Yaku K, Palikhe S, Izumi H, et al. BST1 regulates nicotinamide riboside metabolism via its glycohydrolase and base-exchange activities. Nat Commun. 2021;12:6767.
Lapatto HAK, Kuusela M, Heikkinen A, et al. Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin study. Sci Adv. 2023;9(2):eadd5163.
Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD⁺ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22:119–141.
Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332–1345.
